Article: The Asia-Pacific consensus on ulcerative colitis

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleThe Asia-Pacific consensus on ulcerative colitis
AuthorsOoi, CJ1
Fock, KM10
Makharia, GK8
Goh, KL6
Ling, KL
Hilmi, I6
Lim, WC11
Kelvin, T
Gibson, PR4
Gearry, RB7
Ouyang, Q12
Sollano, J2
Manatsathit, S13
Rerknimitr, R5
Wei, SC3
Leung, WK14
De Silva, HJ9
Leong, RWL
KeywordsChemicals And Cas Registry Numbers
Issue Date2010
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
CitationJournal Of Gastroenterology And Hepatology, 2010, v. 25 n. 3, p. 453-468 [How to Cite?]
DOI: http://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
AbstractInflammatory bowel disease (IBD) is increasing in many parts of the Asia-Pacific region. There is a need to improve the awareness of IBD and develop diagnostic and management recommendations relevant to the region. This evidence-based consensus focuses on the definition, epidemiology and management of ulcerative colitis (UC) in Asia. A multi-disciplinary group developed the consensus statements, reviewed the relevant literature, and voted on them anonymously using the Delphi method. The finalized statements were reviewed to determine the level of consensus, evidence quality and strength of recommendation. Infectious colitis must be excluded prior to diagnosing UC. Typical histology and macroscopic extent of the disease seen in the West is found in the Asia-Pacific region. Ulcerative colitis is increasing in many parts of Asia with gender distribution and age of diagnosis similar to the West. Extra-intestinal manifestations including primary sclerosing cholangitis are rarer than in the West. Clinical stratification of disease severity guides management. In Japan, leukocytapheresis is a treatment option. Access to biologic agents remains limited due to high cost and concern over opportunistic infections. The high endemic rates of hepatitis B virus infection require stringent screening before initiating immune-suppressive agents. Vaccination and prophylactic therapies should be initiated on a case-by-case basis and in accordance with local practice. Colorectal cancer complicates chronic colitis. A recent increase in UC is reported in the Asia-Pacific region. These consensus statements aim to improve the recognition of UC and assist clinicians in its management with particular relevance to the region. © 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
ISSN0815-9319
2011 Impact Factor: 2.865
2011 SCImago Journal Rankings: 0.208
DOIhttp://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
ISI Accession Number IDWOS:000274939900005
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorOoi, CJ
dc.contributor.authorFock, KM
dc.contributor.authorMakharia, GK
dc.contributor.authorGoh, KL
dc.contributor.authorLing, KL
dc.contributor.authorHilmi, I
dc.contributor.authorLim, WC
dc.contributor.authorKelvin, T
dc.contributor.authorGibson, PR
dc.contributor.authorGearry, RB
dc.contributor.authorOuyang, Q
dc.contributor.authorSollano, J
dc.contributor.authorManatsathit, S
dc.contributor.authorRerknimitr, R
dc.contributor.authorWei, SC
dc.contributor.authorLeung, WK
dc.contributor.authorDe Silva, HJ
dc.contributor.authorLeong, RWL
dc.date.accessioned2011-04-04T07:57:24Z
dc.date.available2011-04-04T07:57:24Z
dc.date.issued2010
dc.description.abstractInflammatory bowel disease (IBD) is increasing in many parts of the Asia-Pacific region. There is a need to improve the awareness of IBD and develop diagnostic and management recommendations relevant to the region. This evidence-based consensus focuses on the definition, epidemiology and management of ulcerative colitis (UC) in Asia. A multi-disciplinary group developed the consensus statements, reviewed the relevant literature, and voted on them anonymously using the Delphi method. The finalized statements were reviewed to determine the level of consensus, evidence quality and strength of recommendation. Infectious colitis must be excluded prior to diagnosing UC. Typical histology and macroscopic extent of the disease seen in the West is found in the Asia-Pacific region. Ulcerative colitis is increasing in many parts of Asia with gender distribution and age of diagnosis similar to the West. Extra-intestinal manifestations including primary sclerosing cholangitis are rarer than in the West. Clinical stratification of disease severity guides management. In Japan, leukocytapheresis is a treatment option. Access to biologic agents remains limited due to high cost and concern over opportunistic infections. The high endemic rates of hepatitis B virus infection require stringent screening before initiating immune-suppressive agents. Vaccination and prophylactic therapies should be initiated on a case-by-case basis and in accordance with local practice. Colorectal cancer complicates chronic colitis. A recent increase in UC is reported in the Asia-Pacific region. These consensus statements aim to improve the recognition of UC and assist clinicians in its management with particular relevance to the region. © 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
dc.description.naturelink_to_OA_fulltext
dc.identifier.citationJournal Of Gastroenterology And Hepatology, 2010, v. 25 n. 3, p. 453-468 [How to Cite?]
DOI: http://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
dc.identifier.citeulike6841344
dc.identifier.doihttp://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
dc.identifier.eissn1440-1746
dc.identifier.epage468
dc.identifier.hkuros203859
dc.identifier.isiWOS:000274939900005
dc.identifier.issn0815-9319
2011 Impact Factor: 2.865
2011 SCImago Journal Rankings: 0.208
dc.identifier.issue3
dc.identifier.pmid20370724
dc.identifier.scopuseid_2-s2.0-77649226304
dc.identifier.spage453
dc.identifier.urihttp://hdl.handle.net/10722/132848
dc.identifier.volume25
dc.languageeng
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
dc.publisher.placeAustralia
dc.relation.ispartofJournal of Gastroenterology and Hepatology
dc.relation.referencesReferences in Scopus
dc.subject.meshColitis, Ulcerative - complications - diagnosis - drug therapy - epidemiology - therapy
dc.subject.meshColorectal Neoplasms - etiology
dc.subject.meshCongresses as Topic
dc.subject.meshHumans
dc.subject.meshImmunosuppressive Agents - therapeutic use
dc.subject.meshLeukapheresis - methods
dc.subject.meshPractice Guidelines as Topic
dc.subject.meshPrevalence
dc.subject.meshSeverity of Illness Index
dc.subject.meshSingapore - epidemiology
dc.subjectChemicals And Cas Registry Numbers
dc.titleThe Asia-Pacific consensus on ulcerative colitis
dc.typeArticle
Author Affiliations
  1. Singapore General Hospital
  2. University of Santo Tomas, Manila
  3. National Taiwan University
  4. Monash University
  5. Chulalongkorn University
  6. University of Malaya
  7. University of Otago
  8. All India Institute of Medical Sciences
  9. University of Kelaniya
  10. Changi General Hospital
  11. Tan Tock Seng Hospital
  12. Sichuan University
  13. Mahidol University
  14. Chinese University of Hong Kong
  15. University of New South Wales